Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Does Preoperative Biliary Drainage Influence The Outcome Of Resectional Surgery For Ampullary Carcinoma?
A research article published in the World Journal of Gastroenterology addresses this question. This is believed to be the first study to investigate the effect of PBD in ampullary cancer. A team of gastroenterologists led by Dr Steven Joseph Mesenas and hepatobiliary surgeons at Singapore General Hospital divided 82 patients with ampullary cancer planned for surgical resection into those with PBD (n = 35) and those without (n = 47). The authors looked into various outcomes after surgery, such as pancreatic leakage, wound infection, bile leakage, infectious morbidity, intra-abdominal or gastrointestinal bleeding, intra-abdominal abscess, delayed gastric emptying and mortality. They found that the PBD group had a significantly reduced wound infection rate compared to the non-PBD group. More studies should be conducted to assess this benefit, especially in ampullary cancer patients.
generic viagra online
American Woman Becomes First Person With Diagnosed Multiple Sclerosis To Reach The Top Of MT Everest
American climber Lori Schneider of the US State of Wisconsin has become what is believed to be the first person with diagnosed multiple sclerosis to get to the top of Mt Everest. Lori Schneider, aged 52, reached the top of the world in the early hours of Saturday morning London time, carrying with her a banner celebrating the upcoming World MS (Multiple Sclerosis) Day on Wednesday 27 May (http://www.worldmsday.org). The banner reads: "Join the Global Movement. End MS!" (Note to picture editors: photo will be available as soon as Lori Schneider descends).
News of the day
A Real-Life Example Of Humans' Dual Vision System
It"s rare when real-world events perfectly mirror experiments that scientists are conducting.
Endocrinology

New Research Shows: Neurofeedback Is An 'Evidence-Based' Treatment For ADHD

Neurofeedback - also called EEG Biofeedback - is a method used to train brain activity in order to normalize Brain function and treat psychiatric disorders. This treatment method has gained interest over the last 10 years, however the question whether this treatment should be regarded as an Evidence-Based treatment was unanswered until now. Tomorrow a study will be published in the scientific journal "EEG and Clinical Neuroscience" demonstrating that Neurofeedback can indeed be regarded as an evidence-based treatment for Attention Deficit- / Hyperactivity Disorder (ADHD). Neurofeedback is a treatment where real-time feedback is provided for specific brain activity (most often EEG) in order to learn the brain to suppress or produce specific brain activity. This method was initially discovered for the treatment of Epilepsy and from 1976 investigated further for the treatment of ADHD. This technique has become more popular by clinicians worldwide, and is currently provided for the treatment of several disorders. Critics have often questioned the efficacy of Neurofeedback and whether it can be considered an Evidence Based treatment or not. In collaboration with researchers from Tubingen University (Germany), Radboud University (Nijmegen, the Netherlands), Brainclinics and EEG Re Institute a so-called meta-analysis was conducted on all published research about Neurofeedback treatment in ADHD. This meta-analysis included 15 studies and 1194 ADHD patients. Based on this study - which will be published in the July issue of EEG and Clinical Neuroscience - it could be concluded that Neurofeedback can indeed be considered an Evidence-Based treatment for ADHD. The results show that neurofeedback treatment has large and clinically significant effects on Impulsivity and Inattention and a modest improvement of Hyperactivity. These findings apply to Neurofeedback treatment for ADHD, but do not automatically imply that Neurofeedback can be considered evidence based for any disorder. The efficacy of Neurofeedback has to be assessed separately for each disorder. For example, a meta-analysis of EEG biofeedback in Epilepsy is published in the same issue of EEG and Clinical Neuroscience demonstrating clinical efficacy in the treatment of epilepsy. Interested clients are advised to make an informed choice regarding Neurofeedback therapists, since there is a large heterogeneity in neurofeedback treatment approaches and clinicians. It is advised to look for psychologists or physicians who are a member of a professional organization such as the International Society for Neurofeedback and Research (ISNR: http://www.isnr.org) or other professional organizations. Literature Arns, M., de Ridder, S., Strehl, U., Breteler, M. & Coenen, A. Efficacy of Neurofeedback Treatment in ADHD: The effects on Inattention, Impulsivity and Hyperactivity: a Meta-Analysis. EEG and Clinical Neuroscience; 40(3), 180-189. Brainclinics is specialized in Personalized Medicine, applied Neuroscience and diagnostics of Brain related disorders. Furthermore, Brainclinics is specialized in innovative new - evidence-based - treatments such as rTMS for Depression and Neurofeedback for the treatment of ADHD. Employing applied Brain research Brainclinics strives to improve and personalize treatments in order to achieve more efficacious clinical outcomes (also called Personalized Medicine). Brainclinics Treatment B.V.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009